Superion(®) InterSpinous Spacer for treatment of moderate degenerative lumbar spinal stenosis: durable three-year results of a randomized controlled trial

PURPOSE: This report provides the 3-year clinical outcomes from the randomized, controlled US Food and Drug Administration Investigational Device Exemption trial of the Superion(®) for the treatment of moderate degenerative lumbar spinal stenosis. PATIENTS AND METHODS: The Superion(®) was evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Vikas V, Nunley, Pierce D, Whang, Peter G, Haley, Thomas R, Bradley, W Daniel, Davis, Raphael P, Block, Jon E, Geisler, Fred H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599047/
https://www.ncbi.nlm.nih.gov/pubmed/26491369
http://dx.doi.org/10.2147/JPR.S92633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599047/
https://www.ncbi.nlm.nih.gov/pubmed/26491369
http://dx.doi.org/10.2147/JPR.S92633

Ejemplares similares